Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis involvement of Giα2-linked Rho kinase activity

F. Liu, A. D. Verin, P. Wang, R. Day, R. P. Wersto, F. J. Chrest, D. K. English, J. G.N. Garcia

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

We compared stimulus-coupling pathways involved in bovine pulmonary artery (PA) and lung microvascular endothelial cell migration evoked by sphingosine-1-phosphate (S1P), a potent bioactive lipid released from activated platelets, and by vascular endothelial growth factor (VEGF), a well-recognized angiogenic factor. S1P-induced endothelial cell migration was maximum at 1 μM (∼ 8-fold increase with PA endothelium) and surpassed the maximal response evoked by either VEGF (10 ng/ml) (∼ 2.5-fold increase) or hepatocyte growth factor (HGF) (∼ 2.5-fold increase). Migration induced by S1P, but not by VEGF, was significantly inhibited by treatment with antisense oligonucleotides directed to Edg-1 and Edg-3 (endothelial differentiation gene) S1P receptors and by G protein modification. These strategies included pretreatment with pertussis toxin, or transfection with mini-genes encoding a βγ subunit inhibitory peptide of the β-adrenergic receptor kinase, or an 11-amino-acid peptide that inhibits G1α2 signaling. Various strategies to interrupt Rho family signaling, including C3 exotoxin, dominant/negative Rho, or the addition of Y27632, a cell-permeable Rho kinase inhibitor, significantly attenuated S1P- but not VEGF-induced migration. Conversely, pharmacologic inhibition of either myosin light chain kinase, src family tyrosine kinases, or phosphatidylinositol-3′ kinase reduced basal endothelial cell migration and abolished VEGF-induced endothelial cell migration but did not inhibit the increase in S1P-induced migration. Whereas VEGF and S1P increased both p42/p44 extracellular regulated kinase and p38 mitogen-activated protein (MAP) kinase activities, only p38 MAP kinase inhibition significantly reduced VEGF- and S1P-stimulated migration. These data confirm S1P as a potent endothelial cell chemoattractant through G1α2-coupled Edg receptors linked to Rho-associated kinase and p38 MAP kinase activation. The divergence in signaling pathways evoked by S1P and VEGF suggests complex and agonist-specific regulation of endothelial cell angiogenic responses.

Original languageEnglish (US)
Pages (from-to)711-719
Number of pages9
JournalAmerican journal of respiratory cell and molecular biology
Volume24
Issue number6
DOIs
StatePublished - Jan 1 2001

Fingerprint

rho-Associated Kinases
Endothelial cells
Chemotaxis
Vascular Endothelial Growth Factor A
Endothelial Cells
Cell Movement
p38 Mitogen-Activated Protein Kinases
Lysosphingolipid Receptors
Pulmonary Artery
Phosphotransferases
Phosphatidylinositol 3-Kinase
Myosin-Light-Chain Kinase
sphingosine 1-phosphate
Exotoxins
Peptides
Gene encoding
Peptide Receptors
Hepatocyte Growth Factor
src-Family Kinases
Antisense Oligonucleotides

ASJC Scopus subject areas

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis involvement of Giα2-linked Rho kinase activity. / Liu, F.; Verin, A. D.; Wang, P.; Day, R.; Wersto, R. P.; Chrest, F. J.; English, D. K.; Garcia, J. G.N.

In: American journal of respiratory cell and molecular biology, Vol. 24, No. 6, 01.01.2001, p. 711-719.

Research output: Contribution to journalArticle

@article{77aed5879ef142659492b68e87f94259,
title = "Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis involvement of Giα2-linked Rho kinase activity",
abstract = "We compared stimulus-coupling pathways involved in bovine pulmonary artery (PA) and lung microvascular endothelial cell migration evoked by sphingosine-1-phosphate (S1P), a potent bioactive lipid released from activated platelets, and by vascular endothelial growth factor (VEGF), a well-recognized angiogenic factor. S1P-induced endothelial cell migration was maximum at 1 μM (∼ 8-fold increase with PA endothelium) and surpassed the maximal response evoked by either VEGF (10 ng/ml) (∼ 2.5-fold increase) or hepatocyte growth factor (HGF) (∼ 2.5-fold increase). Migration induced by S1P, but not by VEGF, was significantly inhibited by treatment with antisense oligonucleotides directed to Edg-1 and Edg-3 (endothelial differentiation gene) S1P receptors and by G protein modification. These strategies included pretreatment with pertussis toxin, or transfection with mini-genes encoding a βγ subunit inhibitory peptide of the β-adrenergic receptor kinase, or an 11-amino-acid peptide that inhibits G1α2 signaling. Various strategies to interrupt Rho family signaling, including C3 exotoxin, dominant/negative Rho, or the addition of Y27632, a cell-permeable Rho kinase inhibitor, significantly attenuated S1P- but not VEGF-induced migration. Conversely, pharmacologic inhibition of either myosin light chain kinase, src family tyrosine kinases, or phosphatidylinositol-3′ kinase reduced basal endothelial cell migration and abolished VEGF-induced endothelial cell migration but did not inhibit the increase in S1P-induced migration. Whereas VEGF and S1P increased both p42/p44 extracellular regulated kinase and p38 mitogen-activated protein (MAP) kinase activities, only p38 MAP kinase inhibition significantly reduced VEGF- and S1P-stimulated migration. These data confirm S1P as a potent endothelial cell chemoattractant through G1α2-coupled Edg receptors linked to Rho-associated kinase and p38 MAP kinase activation. The divergence in signaling pathways evoked by S1P and VEGF suggests complex and agonist-specific regulation of endothelial cell angiogenic responses.",
author = "F. Liu and Verin, {A. D.} and P. Wang and R. Day and Wersto, {R. P.} and Chrest, {F. J.} and English, {D. K.} and Garcia, {J. G.N.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1165/ajrcmb.24.6.4323",
language = "English (US)",
volume = "24",
pages = "711--719",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis involvement of Giα2-linked Rho kinase activity

AU - Liu, F.

AU - Verin, A. D.

AU - Wang, P.

AU - Day, R.

AU - Wersto, R. P.

AU - Chrest, F. J.

AU - English, D. K.

AU - Garcia, J. G.N.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - We compared stimulus-coupling pathways involved in bovine pulmonary artery (PA) and lung microvascular endothelial cell migration evoked by sphingosine-1-phosphate (S1P), a potent bioactive lipid released from activated platelets, and by vascular endothelial growth factor (VEGF), a well-recognized angiogenic factor. S1P-induced endothelial cell migration was maximum at 1 μM (∼ 8-fold increase with PA endothelium) and surpassed the maximal response evoked by either VEGF (10 ng/ml) (∼ 2.5-fold increase) or hepatocyte growth factor (HGF) (∼ 2.5-fold increase). Migration induced by S1P, but not by VEGF, was significantly inhibited by treatment with antisense oligonucleotides directed to Edg-1 and Edg-3 (endothelial differentiation gene) S1P receptors and by G protein modification. These strategies included pretreatment with pertussis toxin, or transfection with mini-genes encoding a βγ subunit inhibitory peptide of the β-adrenergic receptor kinase, or an 11-amino-acid peptide that inhibits G1α2 signaling. Various strategies to interrupt Rho family signaling, including C3 exotoxin, dominant/negative Rho, or the addition of Y27632, a cell-permeable Rho kinase inhibitor, significantly attenuated S1P- but not VEGF-induced migration. Conversely, pharmacologic inhibition of either myosin light chain kinase, src family tyrosine kinases, or phosphatidylinositol-3′ kinase reduced basal endothelial cell migration and abolished VEGF-induced endothelial cell migration but did not inhibit the increase in S1P-induced migration. Whereas VEGF and S1P increased both p42/p44 extracellular regulated kinase and p38 mitogen-activated protein (MAP) kinase activities, only p38 MAP kinase inhibition significantly reduced VEGF- and S1P-stimulated migration. These data confirm S1P as a potent endothelial cell chemoattractant through G1α2-coupled Edg receptors linked to Rho-associated kinase and p38 MAP kinase activation. The divergence in signaling pathways evoked by S1P and VEGF suggests complex and agonist-specific regulation of endothelial cell angiogenic responses.

AB - We compared stimulus-coupling pathways involved in bovine pulmonary artery (PA) and lung microvascular endothelial cell migration evoked by sphingosine-1-phosphate (S1P), a potent bioactive lipid released from activated platelets, and by vascular endothelial growth factor (VEGF), a well-recognized angiogenic factor. S1P-induced endothelial cell migration was maximum at 1 μM (∼ 8-fold increase with PA endothelium) and surpassed the maximal response evoked by either VEGF (10 ng/ml) (∼ 2.5-fold increase) or hepatocyte growth factor (HGF) (∼ 2.5-fold increase). Migration induced by S1P, but not by VEGF, was significantly inhibited by treatment with antisense oligonucleotides directed to Edg-1 and Edg-3 (endothelial differentiation gene) S1P receptors and by G protein modification. These strategies included pretreatment with pertussis toxin, or transfection with mini-genes encoding a βγ subunit inhibitory peptide of the β-adrenergic receptor kinase, or an 11-amino-acid peptide that inhibits G1α2 signaling. Various strategies to interrupt Rho family signaling, including C3 exotoxin, dominant/negative Rho, or the addition of Y27632, a cell-permeable Rho kinase inhibitor, significantly attenuated S1P- but not VEGF-induced migration. Conversely, pharmacologic inhibition of either myosin light chain kinase, src family tyrosine kinases, or phosphatidylinositol-3′ kinase reduced basal endothelial cell migration and abolished VEGF-induced endothelial cell migration but did not inhibit the increase in S1P-induced migration. Whereas VEGF and S1P increased both p42/p44 extracellular regulated kinase and p38 mitogen-activated protein (MAP) kinase activities, only p38 MAP kinase inhibition significantly reduced VEGF- and S1P-stimulated migration. These data confirm S1P as a potent endothelial cell chemoattractant through G1α2-coupled Edg receptors linked to Rho-associated kinase and p38 MAP kinase activation. The divergence in signaling pathways evoked by S1P and VEGF suggests complex and agonist-specific regulation of endothelial cell angiogenic responses.

UR - http://www.scopus.com/inward/record.url?scp=0034974903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034974903&partnerID=8YFLogxK

U2 - 10.1165/ajrcmb.24.6.4323

DO - 10.1165/ajrcmb.24.6.4323

M3 - Article

C2 - 11415936

AN - SCOPUS:0034974903

VL - 24

SP - 711

EP - 719

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 6

ER -